Swiss drugs regulator approves first bivalent COVID-19 booster

Download

Swiss drugs regulator Swissmedic said on Monday that it has approved the first bivalent COVID-19 booster vaccine in the country.

Moderna's Spikevax vaccine, which contains mRNA against two COVID-19 variants, is authorized for anyone aged 18 years or older, said Swissmedic.

Source(s): Reuters